Filed: 8/14/2024ACC: 0001420506-24-001566
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $3.19B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$3.19B
Total AUM (reported)
1.48B
Total Shares
Allocation by class
COM$1.45B45.4%
NOTE11/1$208.12M6.5%
NOTE 2.500% 3/1$142.97M4.5%
COM NEW$140.70M4.4%
NOTE11/0$129.79M4.1%
NOTE 0.375% 3/1$110.07M3.5%
COM CL A$103.38M3.2%
Portfolio Concentration
Top 3$480.87M15.1%
4–10$688.50M21.6%
11–25$993.60M31.2%
Rest$1.02B32.1%
Top 3 weight
15.1%
Top 10 weight
36.7%
Voting Authority Distribution
Total shares with voting rights: 1.48B
Sole
Full voting authority
1.48B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings75
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$208.12M
6.53%
Sole
268.25M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares140.84M
TypePRN
Market value$142.97M
4.48%
Sole
140.84M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares140.83M
TypePRN
Market value$129.79M
4.07%
Sole
140.83M
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares114.21M
TypePRN
Market value$110.07M
3.45%
Sole
114.21M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares759.01K
TypeSH
Market value$104.49M
3.28%
Sole
759.01K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares3.31M
TypeSH
Market value$104.48M
3.28%
Sole
3.31M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares2.56M
TypeSH
Market value$99.84M
3.13%
Sole
2.56M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares2.39M
TypeSH
Market value$94.13M
2.95%
Sole
2.39M
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares116.38M
TypePRN
Market value$90.85M
2.85%
Sole
116.38M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares89.74M
TypePRN
Market value$84.65M
2.66%
Sole
89.74M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares82.70M
TypePRN
Market value$81.21M
2.55%
Sole
82.70M
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares2.81M
TypeSH
Market value$81.09M
2.54%
Sole
2.81M
Shared
0.00
None
0.00
INSULET CORP
SOLEShares68M
TypePRN
Market value$74.41M
2.33%
Sole
68M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares1.67M
TypeSH
Market value$73.95M
2.32%
Sole
1.67M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares73.50M
TypePRN
Market value$73.78M
2.31%
Sole
73.50M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares166.92K
TypeSH
Market value$71.78M
2.25%
Sole
166.92K
Shared
0.00
None
0.00
ALIGN TECHNOLOGY INC
SOLEShares275.21K
TypeSH
Market value$66.44M
2.08%
Sole
275.21K
Shared
0.00
None
0.00
MARAVAI LIFESCIENCES HLDGS I
SOLEShares9.02M
TypeSH
Market value$64.61M
2.03%
Sole
9.02M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares808.30K
TypeSH
Market value$61.03M
1.91%
Sole
808.30K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.51M
TypeSH
Market value$59.12M
1.85%
Sole
2.51M
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares496.58K
TypeSH
Market value$58.77M
1.84%
Sole
496.58K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares1.11M
TypeSH
Market value$58.68M
1.84%
Sole
1.11M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares526.36K
TypeSH
Market value$56.66M
1.78%
Sole
526.36K
Shared
0.00
None
0.00
ALPHATEC HLDGS INC
SOLEShares58.22M
TypePRN
Market value$56.55M
1.77%
Sole
58.22M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares43.07M
TypePRN
Market value$55.51M
1.74%
Sole
43.07M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE11/1 | 268.25M | PRN | $208.12M 6.53% | 268.25M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 140.84M | PRN | $142.97M 4.48% | 140.84M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE11/0 | 140.83M | PRN | $129.79M 4.07% | 140.83M | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 114.21M | PRN | $110.07M 3.45% | 114.21M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 759.01K | SH | $104.49M 3.28% | 759.01K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 3.31M | SH | $104.48M 3.28% | 3.31M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 2.56M | SH | $99.84M 3.13% | 2.56M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 2.39M | SH | $94.13M 2.95% | 2.39M | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | NOTE 0.250% 1/1 | 116.38M | PRN | $90.85M 2.85% | 116.38M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | NOTE 1.500% 6/1 | 89.74M | PRN | $84.65M 2.66% | 89.74M | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.375% 5/1 | 82.70M | PRN | $81.21M 2.55% | 82.70M | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 2.81M | SH | $81.09M 2.54% | 2.81M | 0.00 | 0.00 |
INSULET CORPSOLE | NOTE 0.375% 9/0 | 68M | PRN | $74.41M 2.33% | 68M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 1.67M | SH | $73.95M 2.32% | 1.67M | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.250%11/1 | 73.50M | PRN | $73.78M 2.31% | 73.50M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 166.92K | SH | $71.78M 2.25% | 166.92K | 0.00 | 0.00 |
ALIGN TECHNOLOGY INCSOLE | COM | 275.21K | SH | $66.44M 2.08% | 275.21K | 0.00 | 0.00 |
MARAVAI LIFESCIENCES HLDGS ISOLE | COM CL A | 9.02M | SH | $64.61M 2.03% | 9.02M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 808.30K | SH | $61.03M 1.91% | 808.30K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.51M | SH | $59.12M 1.85% | 2.51M | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 496.58K | SH | $58.77M 1.84% | 496.58K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 1.11M | SH | $58.68M 1.84% | 1.11M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 526.36K | SH | $56.66M 1.78% | 526.36K | 0.00 | 0.00 |
ALPHATEC HLDGS INCSOLE | NOTE 0.750% 8/0 | 58.22M | PRN | $56.55M 1.77% | 58.22M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | NOTE 1.250% 9/1 | 43.07M | PRN | $55.51M 1.74% | 43.07M | 0.00 | 0.00 |
Page 1 of 3